Chuck Shih leads Pew’s drug spending research initiative, which identifies policy options to help manage drug costs and ensure that patients have access to lifesaving treatments.
Prior to joining Pew, he held a fellowship in health policy at the National Pharmaceutical Council and George Washington University School of Public Health and Health Services.
Shih previously worked at the Centers for Medicare & Medicaid Services, where he was an analyst in the Coverage and Analysis Group and developed Medicare coverage policies for medical devices, pharmaceuticals, and procedures. He also served as a fellow at the Agency for Healthcare Research and Quality, where he advanced and implemented the Healthcare Horizon Scanning System, and served as a project officer for the creation of comparative effectiveness evidence reports and systematic reviews in the Effective Health Care Program.
Shih received a doctorate and master of health science degree from Johns Hopkins Bloomberg School of Public Health and a bachelor’s degree from Johns Hopkins University.
Recent WorkView All
Many proposed policies to reduce Medicare drug spending would require new legislation, but it’s possible the program could achieve some savings with an existing approach known as the national coverage determination (NCD) process. Read More
In recent years, the high cost of prescription drugs in the United States has been the subject of much public discussion. While attention has been focused on a few instances of what critics see as the most outrageous price increases, policymakers should also recognize that Americans spend twice as much per person on prescription drugs as do people in other high-income countries. Clearly, the... Read More
U.S. policymakers and patients continue to grapple with rising pharmaceutical spending, which accounted for $310 billion in 2015, an increase of almost 9 percent from the previous year. And costs are expected to continue to rise as high-priced brand-name and specialty medications hit the market. New branded drugs accounted for $24 billion in spending in 2015, while Medicare costs for specialty... Read More